Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Morales La Madrid

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Targeted Oncology|September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastomaAndres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Current Cancer Drug Targets|February 9, 2017
Epigenetics in Clinical Management of Children and Adolescents with Brain TumorsAndres Morales La Madrid, Mark W Kieran
Frontiers in Oncology|July 21, 2015
Future Clinical Trials in DIPG: Bringing Epigenetics to the ClinicAndres Morales La Madrid, Rintaro Hashizume, Mark W Kieran
Journal of Neuro-Oncology|July 13, 2018
Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USAAndres Morales La Madrid, Surabhi Ranjan, Katherine E Warren
Pediatric Blood & Cancer|April 12, 2011
Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastomaAndres Morales La Madrid, Charles M Rubin, Michael Kohrman, et al.
Pediatric Blood & Cancer|July 29, 2016
Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, FranceJeffrey P Greenfield, Alicia Castañeda Heredia, Emilie George, et al.
Neurology|January 14, 2021
Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus SyndromeMar Petit-Pedrol, Mar Guasp, Thais Armangue, et al.
Pediatric Blood & Cancer|January 14, 2025
Achieving Language Justice in Pediatric Hematology-Oncology: A Multinational Perspective for Language-Concordant Equitable Patient- and Family-Centered Care and Research InclusionJenny Ruiz, Joanna M Robles, Luisanna M Sánchez, et al.
EJC Paediatric Oncology|December 10, 2025
Childhood cancer survival in low- and middle-income countries and the Global South: emerging evidence and critical gaps from a scoping review of observational studiesMarilina Santero, Roberta Ortiz Sequeira, Margarida Cruz Paixao, et al.
Pediatric Blood & Cancer|January 4, 2012
Locoregional MYCN-amplified neuroblastomaAndres Morales La Madrid, Samuel Volchenboum, Julie M Gastier-Foster, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Targeted Oncology|September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastomaAndres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Current Cancer Drug Targets|February 9, 2017
Epigenetics in Clinical Management of Children and Adolescents with Brain TumorsAndres Morales La Madrid, Mark W Kieran
Frontiers in Oncology|July 21, 2015
Future Clinical Trials in DIPG: Bringing Epigenetics to the ClinicAndres Morales La Madrid, Rintaro Hashizume, Mark W Kieran
Journal of Neuro-Oncology|July 13, 2018
Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USAAndres Morales La Madrid, Surabhi Ranjan, Katherine E Warren
Pediatric Blood & Cancer|April 12, 2011
Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastomaAndres Morales La Madrid, Charles M Rubin, Michael Kohrman, et al.
Pediatric Blood & Cancer|July 29, 2016
Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, FranceJeffrey P Greenfield, Alicia Castañeda Heredia, Emilie George, et al.
Neurology|January 14, 2021
Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus SyndromeMar Petit-Pedrol, Mar Guasp, Thais Armangue, et al.
Pediatric Blood & Cancer|January 14, 2025
Achieving Language Justice in Pediatric Hematology-Oncology: A Multinational Perspective for Language-Concordant Equitable Patient- and Family-Centered Care and Research InclusionJenny Ruiz, Joanna M Robles, Luisanna M Sánchez, et al.
EJC Paediatric Oncology|December 10, 2025
Childhood cancer survival in low- and middle-income countries and the Global South: emerging evidence and critical gaps from a scoping review of observational studiesMarilina Santero, Roberta Ortiz Sequeira, Margarida Cruz Paixao, et al.
Pediatric Blood & Cancer|January 4, 2012
Locoregional MYCN-amplified neuroblastomaAndres Morales La Madrid, Samuel Volchenboum, Julie M Gastier-Foster, et al.
Pageof 5